Cafepharma Today

November 1 2024 - Novo, with new results, to seek approval for obesity drug in MASH
Novo, with new results, to seek approval for obesity drug in MASH
FDA reconsiders CAR-T boxed warning on secondary cancers
Drug pricing and the 2024 presidential election
Lexicon's type 1 diabetes drug voted down by FDA adcomm
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Synta's billion-dollar drug nears end of Phase III
Fierce Biotech
Monday, February 2, 2009 - 10:43am
tags:
Synta, drug trials, cancer, elesclomol, GSK
Cephalon licenses lupus drug candidate from ImmuPharma, moves program further in development
Yahoo/AP
Monday, February 2, 2009 - 10:08am
tags:
lupus, ImmuPharma, Cephalon
Will 2009 Be a Year for Pharma Currency Speculators?
Seeking Alpha
Monday, February 2, 2009 - 9:37am
tags:
pharma industry
Pfizer-Wyeth Merger Looks Unwise
Seeking Alpha
Monday, February 2, 2009 - 9:31am
tags:
Pfizer, Wyeth, buyouts
Schering earnings expected to show cost cuts
Yahoo/AP
Monday, February 2, 2009 - 9:30am
tags:
Schering Plough, earnings, hepatitis C
China Biopharma News from a Holiday Week
Seeking Alpha
Monday, February 2, 2009 - 9:22am
tags:
China, NovaMed, Tianyin Pharmaceutical
Pfizer's Friday Night Lights Out
CNBC
Monday, February 2, 2009 - 9:08am
tags:
Pfizer, pancreatic cancer, Wyeth, buyouts
Pozen Poised to Fill a Healthcare Void
Seeking Alpha
Monday, February 2, 2009 - 8:06am
tags:
Pozen, AstraZeneca, chronic pain, arthritis
Gilead Sciences: Great Quarter, Strong Anti-Viral Franchise Make It a Buy
Seeking Alpha
Monday, February 2, 2009 - 8:05am
tags:
Gilead Sciences, earnings
Sanofi to join Pfizer on acquisition trail
FT.com
Monday, February 2, 2009 - 8:04am
tags:
Sanofi, Pfizer, Bristol-Myers Squibb, Biogen Idec, Amgen, Crucell
Teva gets generic Risperdal OK
Globes, Israel
Sunday, February 1, 2009 - 10:34am
tags:
Teva Pharmaceuticals, Risperdal
Call for end to drug firms' gifts (in the UK)
BBC News, UK
Sunday, February 1, 2009 - 10:29am
tags:
Sun interested in acquiring a generic firm in US
Hindustan Times, India
Sunday, February 1, 2009 - 10:28am
tags:
Sun Pharma
Biotech firms warned they must use intellectual assets as loan collatera
Scotsman, UK
Sunday, February 1, 2009 - 10:26am
tags:
biotech
GlaxoSmithkline to cut 6,000 jobs: report
Yahoo/Reuters
Sunday, February 1, 2009 - 10:16am
tags:
GSK
Why Roche Went Hostile For Genentech (video)
The Street
Sunday, February 1, 2009 - 10:14am
tags:
Roche, Genentech
FDA Warns Consumers About Tainted Diet Pills
MSNBC
Saturday, January 31, 2009 - 12:31pm
tags:
Novartis And Medicines For Malaria Venture Launch Coartem® Dispersible, The First ACT* Developed For Children Suffering From Malaria
Medical News Today
Saturday, January 31, 2009 - 12:29pm
tags:
Novartis
Lilly’s new twist
Indianapolis Business Journal, IN
Saturday, January 31, 2009 - 12:27pm
tags:
Eli Lilly
Pfizer/Wyeth deal poses antitrust test to Obama
Journal Inquirer, CT
Saturday, January 31, 2009 - 12:26pm
tags:
Pfizer, Wyeth

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
Drug Channels
Eli Lilly's Earnings
In the Pipeline
The Choice
In the Pipeline
Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments
Drug Channels
GLP-1 For Everything
In the Pipeline
No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
Drug Channels
A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement- Phoenix, AZ
Phoenix, Arizona,
Otsuka
Account Manager-Queens West, NY-Ophthalmics
Rego Park, New York, 11374
Sun Pharmaceutical Industries, Inc.
Account Manager-Queens West, NY-Ophthalmics
East Orange, New Jersey, 07017
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement - San Diego S, CA
San Diego, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Thousand Oaks, CA
Thousand Oaks, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia,
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon,
Otsuka
Pharmaceutical Sales Customer Engagement - Portland E, OR
Portland, Oregon,
Otsuka
Psychiatry Account Manager - Greenville West, SC
Greenville, South Carolina, US
Lundbeck
Account Manager-Queens West, NY-Ophthalmics
Passaic, New Jersey, 07055
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information